Cargando…

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases

Epstein–Barr virus-positive T-cell lymphoproliferative diseases (EBV-T-LPDs) are rare lymphomas with poor prognosis. Although chemotherapeutic strategies such as CHOP have been often selected, they have exhibited only limited efficacy. To clarify the mechanism of chemoresistance, we examined P-glyco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimori, Mayumi, Takada, Honami, Imadome, Ken-Ichi, Kurata, Morito, Yamamoto, Kouhei, Koyama, Takatoshi, Shimizu, Norio, Fujiwara, Shigeyoshi, Miura, Osamu, Arai, Ayako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618620/ https://www.ncbi.nlm.nih.gov/pubmed/26153782 http://dx.doi.org/10.1002/cam4.494

Ejemplares similares

EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals
por: Yoshimori, Mayumi, et al.
Publicado: (2014)

STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
por: Onozawa, Erika, et al.
Publicado: (2018)

Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
por: Yoshimori, Mayumi, et al.
Publicado: (2021)

The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection
por: Ohashi, Ayaka, et al.
Publicado: (2022)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Novel Mouse Xenograft Models Reveal a Critical Role of CD4(+) T Cells in the Proliferation of EBV-Infected T and NK Cells
por: Imadome, Ken-Ichi, et al.
Publicado: (2011)

Modeling EBV infection and pathogenesis in new-generation humanized mice
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2015)

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012)

Gene expression profiling of primary vitreoretinal lymphoma
por: Arai, Ayako, et al.
Publicado: (2020)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2013)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis
por: Imai, Ayano, et al.
Publicado: (2017)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease
por: Staples, Emily, et al.
Publicado: (2020)

Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2018)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
por: Bülbül, Göksenil, et al.
Publicado: (2022)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia
por: Sugimoto-Sekiguchi, Hiroko, et al.
Publicado: (2012)

Efficient recruitment of c‐FLIP(L) to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma
por: Masuda, Azuchi, et al.
Publicado: (2020)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

The First Case of Concomitant Mycobacterium Genavense Lymphadenitis and EBV-Positive Lymphoproliferative Disorder
por: Ito, Yusuke, et al.
Publicado: (2020)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

1792. Viral DNA Loads in Various Blood Components of Patients with EBV-Positive T/NK Cell Lymphoproliferative Diseases
por: Kawada, Jun-ichi, et al.
Publicado: (2019)

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
Publicado: (1991)

Recurrent Enteritis Associated with Epstein-Barr Virus-positive CD4(+) T-cell Lymphoproliferative Disorder after Autologous Stem Cell Transplantation
por: Kawaguchi, Shinichiro, et al.
Publicado: (2020)

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease
por: Kinross-Wright, John Jacob, et al.
Publicado: (2018)

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
por: Bacha, Dhouha, et al.
Publicado: (2017)

Intestinal ulcers as an initial finding in EBV-associated lymphoproliferative disorder: A case report
por: Wang, Sizhu, et al.
Publicado: (2020)

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
por: Roncati, Luca, et al.
Publicado: (2020)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
por: Ahmed, Elshafa Hassan, et al.
Publicado: (2021)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

Highlights: Focus on immunodeficiency-associated lymphoproliferative disorders: Current topics on other iatrogenic immunodeficiency-associated lymphoproliferative disorders and EBV-positive mucocutaneous ulcer
por: Sato, Yasuharu
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_senh1687g1trp4qqfus1tgpvbd